CTLA4Ig-based T-cell costimulation blockade is associated with reduction of adenovirus viremia following post-transplantation cyclophosphamide-based haploidentical transplantation.

Jaiswal, Sarita Rani; Bhakuni, Prakash; Bhagawati, Gitali; Chakrabarti, Aditi; Chakrabarti, Suparno

Jaiswal, Sarita Rani; Bhakuni, Prakash; Bhagawati, Gitali; Chakrabarti, Aditi; Chakrabarti, Suparno.

Afiliação

Jaiswal SR; Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, Kolkata, West Bengal, India.
Bhakuni P; Department of Blood and Marrow Transplantation, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi, India.
Bhagawati G; Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, Kolkata, West Bengal, India.
Chakrabarti A; Department of Blood and Marrow Transplantation, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi, India.
Chakrabarti S; Department of Blood and Marrow Transplantation, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi, India.

Bone Marrow Transplant ; 55(3): 649-652, 2020 03.

Article em En | MEDLINE | ID: mdl-31089272

Assuntos

Transplante Haploidêntico; Viremia; Adenoviridae; Ciclofosfamida; Humanos; Linfócitos T

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Viremia / Transplante Haploidêntico Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google